{"transactions":[{"id":731840,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-06-18T23:05:21.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":233957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter"}],"balance_after":233957,"source":{"system":"sec-edgar","filing":"0001493152-26-029420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029420/ownership.xml","form_type":"4"}},{"id":1094629,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:16:07.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on July 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":270000,"derivative":{"exercise_price":2.83,"expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001415889-25-019032","document":"form4-07022025_080748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925019032/form4-07022025_080748.xml","form_type":"4"}},{"id":1562946,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-23T01:00:13.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":323500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024."}],"balance_after":323500,"derivative":{"exercise_price":3.6,"expiration_date":"2034-03-20","underlying":"Class A Common Stock","underlying_shares":323500},"source":{"system":"sec-edgar","filing":"0000950170-24-035572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024035572/ownership.xml","form_type":"4"}},{"id":1704044,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:20.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":54167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on July 29, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years."}],"balance_after":54167,"derivative":{"exercise_price":2.84,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":54167},"source":{"system":"sec-edgar","filing":"0000950170-23-071476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071476/ownership.xml","form_type":"4"}},{"id":1704043,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:20.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":54167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on July 29, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years."}],"balance_after":75833,"derivative":{"exercise_price":11,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":54167},"source":{"system":"sec-edgar","filing":"0000950170-23-071476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071476/ownership.xml","form_type":"4"}},{"id":1704042,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:20.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":43400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."}],"balance_after":43400,"derivative":{"exercise_price":2.84,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":43400},"source":{"system":"sec-edgar","filing":"0000950170-23-071476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071476/ownership.xml","form_type":"4"}},{"id":1704041,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:20.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":31000,"derivative":{"exercise_price":13.21,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":43400},"source":{"system":"sec-edgar","filing":"0000950170-23-071476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071476/ownership.xml","form_type":"4"}},{"id":1704040,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:20.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":171500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."}],"balance_after":171500,"derivative":{"exercise_price":2.84,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":171500},"source":{"system":"sec-edgar","filing":"0000950170-23-071476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071476/ownership.xml","form_type":"4"}},{"id":1704039,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:20.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":171500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":34300,"derivative":{"exercise_price":5.44,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":171500},"source":{"system":"sec-edgar","filing":"0000950170-23-071476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071476/ownership.xml","form_type":"4"}},{"id":1935402,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-30T01:12:44.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":205800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows:  1/4th of the shares subject to the option vest monthly over four years from March 27, 2023."}],"balance_after":205800,"derivative":{"exercise_price":5.44,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":205800},"source":{"system":"sec-edgar","filing":"0001415889-23-005600","document":"form4-03302023_010335.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000141588923005600/form4-03302023_010335.xml","form_type":"4"}},{"id":1935401,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Class A Common Stock","published_at":"2023-03-30T01:12:44.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":139000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares subject to the restricted stock unit grant vest as follows:  1/16th of the RSUs shall vest quarterly over four years from March 27, 2023."}],"balance_after":163216,"source":{"system":"sec-edgar","filing":"0001415889-23-005600","document":"form4-03302023_010335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000141588923005600/form4-03302023_010335.xml","form_type":"4"}},{"id":1938866,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Class A Common Stock","published_at":"2023-03-24T20:05:20.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2498,"price":5.95,"value":14863.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Groen on March 22, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,214 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 1, 2022."}],"balance_after":24216,"source":{"system":"sec-edgar","filing":"0000899243-23-009586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000089924323009586/doc4.xml","form_type":"4"}},{"id":2318449,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-25T01:01:23.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":74400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."}],"balance_after":74400,"derivative":{"exercise_price":13.21,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":74400},"source":{"system":"sec-edgar","filing":"0001209191-22-021014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000120919122021014/doc4.xml","form_type":"4"}},{"id":2318448,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Class A Common Stock","published_at":"2022-03-25T01:01:23.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022."}],"balance_after":24500,"source":{"system":"sec-edgar","filing":"0001209191-22-021014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000120919122021014/doc4.xml","form_type":"4"}}]}